[1] |
Epstein, Andrew J., Peter W. Groeneveld, Michael O. Harhay, Feifei Yang, and Daniel Polsky. “Impact of minimally invasive surgery on medical spending and employee absenteeism.” JAMA surgery 148, no. 7 (2013): 641-647. |
[2] |
Lefebvre, Patrick, Craig I. Coleman, Brahim K. Bookhart, Si-Tien Wang, Samir H. Mody, Kevin N. Tran, Daisy Y. Zhuo, Lynn Huynh, and Edith A. Nutescu. “Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism.” Journal of medical economics 17, no. 1 (2013): 52-64. |
[3] |
Baker, Laurence C., Dendy S. Macaulay, Rachael A. Sorg, Melissa D. Diener, Scott J. Johnson, and Howard G. Birnbaum. “Effects of care management and telehealth: A longitudinal analysis using Medicare data.” Journal of the American Geriatrics Society 61, no. 9 (2013): 1560-1567. |
[4] |
Epstein, Andrew J., Daniel Polsky, Feifei Yang, Lin Yang, and Peter W. Groeneveld. “Coronary revascularization trends in the United States, 2001-2008.” Jama 305, no. 17 (2011): 1769-1776. |
[5] |
Baker, Laurence C., Scott J. Johnson, Dendy Macaulay, and Howard Birnbaum. “Integrated telehealth and care management program for Medicare beneficiaries with chronic disease linked to savings.” Health Affairs 30, no. 9 (2011): 1689-1697. |
[6] |
Groeneveld, Peter W., Andrew J. Epstein, Feifei Yang, Lin Yang, and Daniel Polsky. “Medicare’s policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged.” Health Affairs 30, no. 2 (2011): 312-321. |
[7] |
Groeneveld, Peter W., Daniel Polsky, Feifei Yang, Lin Yang, and Andrew J. Epstein. “The impact of new cardiovascular device technology on health care costs.” Archives of internal medicine 171, no. 14 (2011): 1289-1291. |
[8] |
Epstein, Andrew J. “Effects of report cards on referral patterns to cardiac surgeons.” Journal of health economics 29, no. 5 (2010): 718-731. |
[9] |
El Khoury H, E Merikle, C Roberts, M Wagner, Scott J. Johnson. “Cost-effectiveness of atorvastatin 10mg daily in the primary prevention of major cardiovascular events in patients with type 2 diabetes in Canada.” Canadian Journal of Diabetes 33, no. 4 (2009):363-374. |
[10] |
Ramsey, Scott D., Lauren D. Clarke, Craig S. Roberts, Sean D. Sullivan, Scott J. Johnson, and Larry Z. Liu. “An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes.” Pharmacoeconomics 26, no. 4 (2008): 329-339. |
[11] |
Ketcham, Jonathan D., and Andrew J. Epstein. “Medicaid preferred drug lists’ costs to physicians.” Medical care 46, no. 1 (2008): 9-16. |
[12] |
Ross, Joseph S., Stephen S. Cha, Andrew J. Epstein, Yongfei Wang, Elizabeth H. Bradley, Jeph Herrin, Judith H. Lichtman, Sharon-Lise T. Normand, Frederick A. Masoudi, and Harlan M. Krumholz. “Quality of care for acute myocardial infarction at urban safety-net hospitals.” Health Affairs 26, no. 1 (2007): 238-248. |
[13] |
Ross, Joseph S., Vivian Ho, Yongfei Wang, Stephen S. Cha, Andrew J. Epstein, Frederick A. Masoudi, Brahmajee K. Nallamothu, and Harlan M. Krumholz. “Certificate of need regulation and cardiac catheterization appropriateness after acute myocardial infarction.” Circulation 115, no. 8 (2007): 1012-1019. |
[14] |
Ketcham, Jonathan D., and Andrew J. Epstein. “Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?.” PharmacoEconomics 24, no. 3 (2006): 27-40. |
[15] |
Epstein, Andrew J. “Do cardiac surgery report cards reduce mortality? Assessing the evidence.” Medical Care Research and Review 63, no. 4 (2006): 403-426. |
[16] |
Epstein, Andrew J., Saif S. Rathore, Harlan M. Krumholz, and Kevin GM Volpp. “Volume-based referral for cardiovascular procedures in the United States: a cross-sectional regression analysis.” BMC health services research 5, no. 1 (2005): 42. |
[17] |
Rathore, Saif S., Andrew J. Epstein, Kevin GM Volpp, and Harlan M. Krumholz. “Hospital coronary artery bypass graft surgery volume and patient mortality, 1998–2000.” Annals of surgery 239, no. 1 (2004): 110. |
[18] |
Epstein, Andrew J, Rathore SS, Volpp KGM, Krumholz HM. “Hospital percutaneous coronary intervention volume and patient mortality, 1998-2000: does the evidence support current procedure volume minimums?” Journal of American College of Cardiology 43, no.10 (2004): 1755-1762. |